Open access · US-GOV
via ClinicalTrials.gov Clinical trial
MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy
Authors not listed
Huntington Medical Research Institutes · 2011
Abstract
Cognitively normal individuals, patients with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) will undergo clinical screening, neuropsychological tests, blood and urine analyses, quantitative magnetic resonance imaging (MRI) and proton (1H ) and carbon 13 (13C) magnetic resonance spectroscopy (MRS). Each individual will receive minocycline oral administration for 4 weeks initially, after which MRI, MRS and neuropsychological results will be recorded. If no adverse side effects occur, subjects will continue minocycline administration for an additional 5 months.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2011). MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy. <em>Huntington Medical Research Institutes</em>. https://clinicaltrials.gov/study/NCT01463384
Vancouver
Anonymous. MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy. Huntington Medical Research Institutes. 2011.
BibTeX
@misc{anon2011MRIand,
title = {MRI and MRS Diagnosis and Treatment Monitoring of Alzheimer's Disease With Novel Therapy},
author = {Anonymous},
journal = {Huntington Medical Research Institutes},
year = {2011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Wisconsin, Madison 2019
Open access · US-GOV
Longitudinal Evaluation of [18-F]MK-6240 as a Novel Tau PET Radiotracer in Patients With Alzheimer's Disease Dementia or Mild Cognitive Impairment Compared to Healthy Volunteers
Duke University 2020
Open access · US-GOV
Duke/UNC Alzheimer's Disease Center Clinical Cohort
University Hospital, Montpellier 2025
Open access · US-GOV
Observational Pilot Study of Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease. What Are the Effects of Mnestic or Hedonic Impairment on Emotion, Reminiscence and Musical Enjoyment
Chinese PLA General Hospital 2025
Open access · US-GOV
Ultra-high Field Multimodal and Multinuclear Neuroimaging Cohort Study of Alzheimer's Disease
GeroScience 2026
Citation only
Multimodal prediction of MCI-to-dementia conversion over a two-year window.
NYU Langone Health 2021
Open access · US-GOV